Search

Author/Creator Park, Haeseong

1. A single-institution phase I feasibility study of dose-escalated IMRT for non-operative locally advanced esophageal carcinoma. (September 2021)

Authors:
Vlacich, Gregory; Ballard, Andrew; Badiyan, Shahed N.; Spraker, Matthew; Henke, Lauren; Kim, Hyun; Lockhart, A. Craig; Park, Haeseong; Suresh, Rama; Huang, Yi; Robinson, Cliff G.; Bradley, Jeffrey D.; Samson, Pamela P.
Journal:
Clinical and translational radiation oncology
Issue:
Volume 30(2021)
Page Start:
19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden. (14th August 2018)

Authors:
Liang, Winnie S.; Vergilio, Jo‐Anne; Salhia, Bodour; Huang, Helen J.; Oki, Yasuhiro; Garrido‐Laguna, Ignacio; Park, Haeseong; Westin, Jason R.; Meric‐Bernstam, Funda; Fabrizio, David; Miller, Vincent A.; Stephens, Philip J.; Fanale, Michelle A.; Ross, Jeffrey S.; Janku, Filip
Journal:
Oncologist
Issue:
Volume 24:Number 2(2019)
Page Start:
219
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. CtDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine. (December 2021)

Authors:
Pellini, Bruna; Pejovic, Nadja; Feng, Wenjia; Earland, Noah; Harris, Peter K.; Usmani, Abul; Szymanski, Jeffrey J.; Qaium, Faridi; Mudd, Jacqueline; Petty, Marvin; Jiang, Yuqiu; Singh, Ashla; Maher, Christopher A.; Henke, Lauren E.; Park, Haeseong; Ciorba, Matthew A.; Kim, Hyun; Mutch, Matthew G....
Journal:
JCO precision oncology
Issue:
Volume 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial. Issue 2 (February 2022)

Authors:
Schoenfeld, Jonathan D; Giobbie-Hurder, Anita; Ranasinghe, Srinika; Kao, Katrina Z; Lako, Ana; Tsuji, Junko; Liu, Yang; Brennick, Ryan C; Gentzler, Ryan D; Lee, Carrie; Hubbard, Joleen; Arnold, Susanne M; Abbruzzese, James L; Jabbour, Salma K; Uboha, Nataliya V; Stephans, Kevin L; Johnson, Jennif...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 2(2022)
Page Start:
279
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline. Issue 7 (1st March 2023)

Authors:
Shah, Manish A.; Kennedy, Erin B.; Alarcon-Rozas, Ashley E.; Alcindor, Thierry; Bartley, Angela N.; Malowany, Aubrey Belk; Bhadkamkar, Nishin A.; Deighton, Dana C.; Janjigian, Yelena; Karippot, Asha; Khan, Uqba; King, Daniel A.; Klute, Kelsey; Lacy, Jill; Lee, James J.; Mehta, Rutika; Mukherjee, ...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 7(2023)
Page Start:
1470
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development. Issue 11 (12th September 2022)

Authors:
Steeghs, Neeltje; Hansen, Aaron R.; Hanna, Glenn J.; Garralda, Elena; Park, Haeseong; Strauss, James; Adam, Michael; Campbell, Gossett; Carver, Jennifer; Easton, Rachael; Mays, Katherine; Skrdla, Peter; Struemper, Herbert; Washburn, Michael L.; Matheny, Christopher; Piha‐Paul, Sarina A.
Journal:
Clinical and translational science
Issue:
Volume 15:Issue 11(2022)
Page Start:
2625
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial. Issue 8 (August 2020)

Authors:
Catenacci, Daniel V T; Kang, Yoon-Koo; Park, Haeseong; Uronis, Hope E; Lee, Keun-Wook; Ng, Matthew C H; Enzinger, Peter C; Park, Se Hoon; Gold, Philip J; Lacy, Jill; Hochster, Howard S; Oh, Sang Cheul; Kim, Yeul Hong; Marrone, Kristen A; Kelly, Ronan J; Juergens, Rosalyn A; Kim, Jong Gwang; Bende...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 8(2020)
Page Start:
1066
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. North Central Cancer Treatment Group N10C2 (Alliance). Issue 6 (June 2015)

Authors:
Park, Haeseong; Qin, Rui; Smith, Thomas J.; Atherton, Pamela J.; Barton, Debra L.; Sturtz, Keren; Dakhil, Shaker R.; Anderson, Daniel M.; Flynn, Kathleen; Puttabasavaiah, Suneetha; Le-Lindqwister, Nguyet Anh; Padula, Gilbert D.A.; Loprinzi, Charles L.
Journal:
Menopause
Issue:
Volume 22:Issue 6(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes. Issue 6 (June 2015)

Authors:
Park, Haeseong; Qin, Rui; Smith, Thomas J.; Atherton, Pamela J.; Barton, Debra L.; Sturtz, Keren; Dakhil, Shaker R.; Anderson, Daniel M.; Flynn, Kathleen; Puttabasavaiah, Suneetha; Le-Lindqwister, Nguyet Anh; Padula, Gilbert D.A.; Loprinzi, Charles L.
Journal:
Menopause
Issue:
Volume 22:Issue 6(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗